This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Breast Cancer
and you are
between 18 and 55
years old
The phase for this study is not defined.
Show me locations

The purpose

The objective of this study was to prove the bioequivalence of Exemestane 25 mg tablet under fasted conditions

Provided treatments

  • Drug: exemestane

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01331447. The sponsor of the trial is Roxane Laboratories and it is looking for 12 volunteers for the current phase.
Official trial title:
A Pilot Single Dose, 2-Period, 2-Treatment, 2-Way Bioequivalency Study of Exemestane 25 mg Tablets Under Fasting Conditions